Mirum Pharmaceuticals, Inc. - Common Stock (MIRM)
CUSIP: 604749101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 51,400,915
- Total 13F shares
- 55,393,029
- Share change
- +1,320,571
- Total reported value
- $2,819,019,204
- Put/Call ratio
- 391%
- Price per share
- $50.89
- Number of holders
- 211
- Value change
- +$70,434,976
- Number of buys
- 109
- Number of sells
- 112
Quarterly Holders Quick Answers
What is CUSIP 604749101?
CUSIP 604749101 identifies MIRM - Mirum Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 604749101:
Top shareholders of MIRM - Mirum Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
13%
|
6,795,121
|
$306,120,201 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
9.3%
|
4,766,109
|
$219,247,167 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
6.5%
|
3,339,557
|
$150,447,043 | — | 31 Mar 2025 | |
| BVF INC/IL |
13F
|
Company |
5.4%
|
2,796,513
|
$125,982,911 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
2,540,061
|
$114,429,748 | — | 31 Mar 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
4.9%
|
2,527,000
|
$113,851,178 | — | 31 Mar 2025 | |
| James E. Flynn |
3/4/5
|
* Possible Member of 10% Group, 10%+ Owner |
—
class O/S missing
|
3,244,434
|
$90,958,032 | — | 06 Jun 2022 | |
| Novo Holdings A/S |
13F
|
Company |
2.9%
|
1,500,000
|
$67,575,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
1,494,566
|
$67,330,198 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.8%
|
1,445,995
|
$65,142,075 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.8%
|
1,415,137
|
$63,753,000 | — | 31 Mar 2025 | |
| NEA Partners 16, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,186,243
|
$61,291,541 | — | 13 Jun 2023 | |
| New Enterprise Associates 16, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,186,243
|
$61,291,541 | — | 13 Jun 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
1,237,107
|
$55,731,670 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.3%
|
1,175,000
|
$52,933,750 | — | 31 Mar 2025 | |
| Niall O'Donnell |
3/4/5
|
Director |
—
class O/S missing
|
1,621,118
|
$45,448,205 | — | 11 Nov 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.9%
|
978,067
|
$44,061,917 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
963,665
|
$43,422,906 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.9%
|
951,765
|
$42,877,013 | — | 31 Mar 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.6%
|
813,398
|
$36,643,000 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.5%
|
778,244
|
$35,059,892 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
1.3%
|
654,722
|
$29,495,227 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
606,431
|
$27,319,744 | — | 31 Mar 2025 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.2%
|
603,318
|
$27,179,476 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
593,355
|
$26,730,643 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
1.1%
|
566,271
|
$25,510,509 | — | 31 Mar 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.1%
|
566,155
|
$25,505,000 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
543,277
|
$24,474,628 | — | 31 Mar 2025 | |
| First Turn Management, LLC |
13F
|
Company |
0.98%
|
503,014
|
$22,660,781 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.97%
|
499,183
|
$22,488,194 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.93%
|
479,299
|
$21,592,420 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.93%
|
477,651
|
$21,518,178 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
388,921
|
$17,520,892 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.75%
|
382,979
|
$17,253,204 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.74%
|
378,622
|
$17,056,921 | — | 31 Mar 2025 | |
| Penn Capital Management Company, LLC |
13F
|
Company |
0.73%
|
373,519
|
$16,870,177 | — | 31 Mar 2025 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.71%
|
366,751
|
$16,522,000 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.69%
|
356,276
|
$16,050,234 | — | 31 Mar 2025 | |
| AXA S.A. |
13F
|
Company |
0.68%
|
351,372
|
$15,829,309 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.68%
|
347,366
|
$15,648,838 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.67%
|
345,000
|
$15,542,250 | — | 31 Mar 2025 | |
| Prosight Management, LP |
13F
|
Company |
0.67%
|
343,326
|
$15,466,836 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
327,878
|
$14,770,904 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.61%
|
313,423
|
$14,119,706 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.58%
|
296,887
|
$13,374,766 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.56%
|
287,936
|
$12,971,517 | — | 31 Mar 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.51%
|
260,000
|
$11,741,200 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.51%
|
260,366
|
$11,729,488 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.49%
|
249,318
|
$11,231,776 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.48%
|
246,730
|
$11,115,186 | — | 31 Mar 2025 |
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q2 2025
As of 30 Jun 2025,
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by
211 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,393,029 shares.
The largest 10 holders included
Frazier Life Sciences Management, L.P., JANUS HENDERSON GROUP PLC, BlackRock, Inc., BVF INC/IL, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, NOVO HOLDINGS A/S, PRICE T ROWE ASSOCIATES INC /MD/, CITADEL ADVISORS LLC, and STATE STREET CORP.
This page lists
212
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
213
Q2 2025 holders
211
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.